Epilepsy treatment options and research developments

Epilepsy management primarily relies on pharmacological interventions, with approximately 30 antiseizure medications (ASM) available globally. While non-pharmacological options like resective surgery, dietary modulators, and specialized diets exist, they are only applicable to a small percentage of patients, such as those with focal drug-resistant epilepsy.

Medical history shows a transition from older ASMs, such as phenobarbital and phenytoin, to newer generations of drugs approved since the 1990s, including lamotrigine and levetiracetam. While newer medications often offer improved tolerability, efficacy comparisons vary. Older drugs remain prevalent in low- and middle-income countries due to cost, and in high-income countries as legacy treatments.

Recent research published in Frontiers in Pediatrics specifically examines treatment efficacy for infantile epileptic spasms syndrome in children with trisomy 21, contributing to the broader understanding of specialized epilepsy care.